Hua’s institutional advantage
How diabetes company Hua navigated volatile Hong Kong market to price IPO
The same market forces that drove Hua Medicine Ltd. to reduce the size of its Hong Kong IPO tempered participation by retail investors, which could help keep the Shanghai diabetes company’s share price steady amidst a more volatile market.
Hua shares ended their first day of trading Friday unchanged at HK$8.28. The company raised HK$867 million ($110.5 million) in its offering through the sale of 104.8 million shares at HK$8.28, valuing Hua at HK$8.7